Interim relief to Novartis: Delhi HC reinstates Entresto (Sacubitril-Valsartan) patent in India Farhat Nasim27 Jan 2023 6:26 PM ISTDelhi: In an interim relief to Swiss pharma major Novartis, the Delhi High Court has reinstated Entresto (sacubitril/valsartan) patent in India amid...
Novartis in tight spot as HC stays grant of patent for Entresto amid generics fight Farhat Nasim13 Jan 2023 11:59 AM ISTNew Delhi: Amid the earlier patent of blockbuster heart failure drug Entresto expiring on January 16, 2023 concerns rise for the Swiss multinational...
Patent Infringement case: Delhi HC rules in favour of Natco Pharma Ruchika Sharma6 Dec 2022 12:30 PM ISTNew Delhi: Natco Pharma has recently announced that the company has received a favourable verdict from Delhi High Court in a patent infringement...
Natco Pharma unveils first generic version of Pomalyst capsules in Australia Ruchika Sharma9 Nov 2022 4:01 PM ISTPomalidomide is prescribed for treatment of Multiple Myeloma and Kaposi Sarcoma.
Natco Pharma unveils Chlorantraniliprole (CTPR) formulated product NATGEN in India Ruchika Sharma26 Sept 2022 12:40 PM ISTHyderabad: Drugmaker, Natco Pharma Limited, has recently announced that the company has launched Chlorantraniliprole (CTPR) 18.5% SC under the Brand...
Delhi HC nod to Natco Pharma for launch of Chlorantraniliprole and its formulations Ruchika Sharma20 Sept 2022 11:59 AM ISTCTPR technical is formulated into broadspectrum insecticides used across wide range of crops for pest management.
Natco Pharma secures USFDA nod for Trabectedin for Injection Ruchika Sharma18 Aug 2022 11:23 AM ISTHyderabad: Drugmaker, Natco Pharma Limited has recently announced that the U.S. Food and Drug Administration (USFDA) has granted tentative approval...
Natco Pharma reports multifold rise in net profit to Rs 320.4 crore in Q1 Ruchika Sharma12 Aug 2022 9:30 AM ISTNew Delhi: Natco Pharma Ltd on Tuesday reported a multifold rise in consolidated net profit to Rs 320.4 crore for the first quarter ended June 30, on...
Eyestem raises Rs 51 crore in Series A round led by Biological E, Alkem, Natco and others Ruchika Sharma8 Aug 2022 1:30 PM IST"Post this funding, we will remain focussed on solidifying our cell therapy platform and moving our flagship product for Dry AMD through early...
Natco partner bags USFDA nod for Cabazitaxel Intravenous Powder Ruchika Sharma25 July 2022 12:15 PM ISTHyderabad: Natco Pharma Limited today announced that the U.S. Food and Drug Administration (USFDA) has granted approval to its partner Breckenridge...
Natco Pharma partner Viatris to launch first generic version of Nexavar tablets in US Ruchika Sharma1 Jun 2022 2:42 PM ISTSorafenib is prescribed for treatment of unresectable Hepatocellular Carcinoma (HCC), advanced Renal Cell Carcinoma (RCC) and Differentiated Thyroid...
Patent infringement: JnJ, Momenta Pharma file case against Natco, Mylan Pharma Ruchika Sharma26 May 2022 3:54 PM ISTHyderabad: Johnson & Johnson's and Momenta Pharmaceuticals have filed a lawsuit against Natco Pharma and its marketing partner Mylan...
